Alere Pays $33.2M To Settle False Claims Suit Involving Fast Blood Chemistry Tests

(March 27, 2018, 10:09 AM EDT) -- BALTIMORE — Alere Inc. and subsidiary Alere San Diego (Alere) have agreed to pay $33.2 million to settle False Claims Act allegations that they sold federal health programs rapid blood chemistry...
To view the full article, register now.